These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Update on the anti-programmed cell death-1 receptor antibodies in advanced cutaneous squamous-cell carcinoma. Benzaquen M Dermatol Ther; 2020 May; 33(3):e13325. PubMed ID: 32208547 [TBL] [Abstract][Full Text] [Related]
13. Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma. Baggi A; Quaglino P; Rubatto M; Depenni R; Guida M; Ascierto PA; Trojaniello C; Queirolo P; Saponara M; Peris K; Spagnolo F; Bianchi L; De Galitiis F; Potenza MC; Proietti I; Marconcini R; Botticelli A; Barbieri V; Licitra L; Alfieri S; Ficorella C; Cortellini A; Fargnoli MC; Troiani T; Tondulli L; Bossi P Eur J Cancer; 2021 Nov; 157():250-258. PubMed ID: 34536948 [TBL] [Abstract][Full Text] [Related]
14. Case Series: Cemiplimab and Nivolumab Immunotherapy as Promising Treatment in Advanced or Metastatic Cutaneous Squamous Cell Carcinoma. Lai FY; Clarke R; Cooper P; Stokes J; Calvert P Case Rep Oncol; 2023; 16(1):1156-1165. PubMed ID: 37900839 [TBL] [Abstract][Full Text] [Related]